Finland· FI-REL-REL2129

Divina

A medroxyprogesteron und estrogen product containing estradiol valerate + medroxyprogesterone acetate, registered in Finland by Orion Corporation. The same ATC class is registered in 2 of our 19 countries.

ATC G03FB06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedDivinaATCG03FB06REGISTER NO.FI-REL-REL2129PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Medroxyprogesteron und estrogen is registered in 2 of 19 countries.

Countries holding a registration under ATC G03FB06 (medroxyprogesteron und estrogen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Medroxyprogesteron und estrogen · ATC G03FB06

2 / 19 countries

  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Estradiol valerate + Medroxyprogesterone acetate
Manufacturer
Orion Corporation
Country
Finland (FI)
ATC code
G03FB06
ATC class
Medroxyprogesteron und Estrogen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Medroxyprogesteron und estrogen in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All medroxyprogesteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Czechia · Indivina
  • Germany · Indivina
  • Denmark · Indivina
  • France · Duova
  • United Kingdom (Northern Ireland) · Indivina
  • Norway · Indivina
  • Sweden · Indivina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6e7af06-8b9a-4640-acef-da1900da01b0
GET /v1/drugs/e6e7af06-8b9a-4640-acef-da1900da01b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.75",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "medroksiprogesteroni ja estrogeeni",
  "ma_number": "9490",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2129",
  "authorised_at": "1987-05-27"
}

See everything about medroxyprogesteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.